AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
Clinical trial NCT05182905 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05182905
- Sponsor
- Nader Sanai
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-27
- Primary completion
- 2026-06-10
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.